COLLA GIANPAOLO 4

Accession 0001203606-04-000001

CIK 0000807873other

View on SEC.gov Company Profile

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 8:37 PM ET

Size

36.1 KB

Accession

0001203606-04-000001

Insider Transaction Report

Form 4

Period: 2004-01-21

SICOR INCscri

COLLA GIANPAOLO

EVP, Italian Operations

Transactions

Sale
Common Stock
2004-01-21$27.76/sh−15,000$416,400→ 0 total
Sale
Common Stock
2004-01-21$27.76/sh−25,000$694,000→ 0 total
Exercise/Conversion
Common Stock
2004-01-21$9.75/sh+10,000$97,500→ 0 total
Exercise/Conversion
Common Stock
2004-01-21$15.19/sh+15,000$227,850→ 0 total
Exercise/Conversion
Employee Stock Option (right to buy)
2004-01-21−15,000→ 0 total
Exercise: $15.19Exp: 2013-03-11→ Common Stock (15,000 underlying)
Sale
Common Stock
2004-01-21$27.60/sh−10,000$276,000→ 0 total
Exercise/Conversion
Employee Stock Option (right to buy)
2004-01-21−10,000→ 0 total
Exercise: $9.75Exp: 2010-02-25→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock
2004-01-21$4.63/sh+25,000$115,625→ 0 total
Exercise/Conversion
Employee Stock Option (right to buy)
2004-01-02−25,000→ 0 total
Exercise: $4.63Exp: 2007-07-28→ Common Stock (25,000 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2004-01-21−25,000→ 0 total
Exercise: $6.48Exp: 2010-01-25→ Common Stock (25,000 underlying)

Footnotes (6)

[F1]This option, which provided for daily vesting in equal installments over a four year period beginning on July 28, 1997
[F2]This option, which provided for daily vesting in equal installments over a four year period beginning on January 25, 2000, accelerated in full upon approval by stockholders of SICOR Inc. of the Agreement and Plan of Merger dated as October 31, 2003, by and among SICOR Inc., Teva Pharmaceutical Industries Limited ("Teva") and a wholly owned subsidiary of Teva."
[F3]This option, which provided for daily vesting in equal installments over a four year period beginning on February 25, 2000, accelerated in full upon approval by stockholders of SICOR Inc. of the Agreement and Plan of Merger dated as October 31, 2003, by and among SICOR Inc., Teva Pharmaceutical Industries Limited ("Teva") and a wholly owned subsidiary of Teva."
[F4]This option, which provided for daily vesting in equal installments over a four year period beginning on February 26, 2001, accelerated in full upon approval by stockholders of SICOR Inc. of the Agreement and Plan of Merger dated as October 31, 2003, by and among SICOR Inc., Teva Pharmaceutical Industries Limited ("Teva") and a wholly owned subsidiary of Teva."
[F5]This option, which provided for daily vesting in equal installments over a four year period beginning on March 8, 2002, accelerated in full upon approval by stockholders of SICOR Inc. of the Agreement and Plan of Merger dated as October 31, 2003, by and among SICOR Inc., Teva Pharmaceutical Industries Limited ("Teva") and a wholly owned subsidiary of Teva."
[F6]This option, which provided for daily vesting in equal installments over a four year period beginning on March 11, 2003, accelerated in full upon approval by stockholders of SICOR Inc. of the Agreement and Plan of Merger dated as October 31, 2003, by and among SICOR Inc., Teva Pharmaceutical Industries Limited ("Teva") and a wholly owned subsidiary of Teva."

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

SICOR INC

CIK 0000807873

→

Entity typeother

Related Parties

filerCIK 0001203606

Filing Metadata

Form type: 4
Filed: Jan 25, 7:00 PM ET
Accepted: Jan 26, 8:37 PM ET
Size: 36.1 KB

View on SEC.gov